Greenline Partners »

Phathom Pharmaceuticals shares owned by Greenline Partners

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Greenline Partners from 13F filings

Historical chart of Greenline Partners investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Greenline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Greenline Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.1k 500 8.12

More positions owned by Greenline Partners

Spdr Gold Minishares Trust Of Beneficial Interest Etf (GLDM)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Total International Stock Etf Etf (VXUS)
Avantis International Small Cap Value Etf Etf (AVDV)
Berkshire Hathaway (BRK.B)
Avantis U.s. Small Cap Value Etf Etf (AVUV)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Ishares Msci Global Metals & Mining Producers Etf Etf (PICK)
Vanguard Ftse Pacific Etf Etf (VPL)
Alphabet Inc Class C cs (GOOG)
Enbridge (ENB)
Cheniere Energy Com New (LNG)
Tc Energy Corp (TRP)
Schwab Us Tips Etf Etf (SCHP)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)

View all positions for Greenline Partners

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Millennium Management
Invesco
Carlyle
BlackRock
Vanguard Group
Ensign Peak Advisors
NEA Management Company
683 Capital Management
Daniel D. Thurber
Catalys Pacific
Jennifer Ranahan
Catalio Capital Management
Geode Capital Management

View all funds holding Phathom Pharmaceuticals